QUANTIFYING THE ASSOCIATION BETWEEN HEALTH-RELATED QUALITY OF LIFE (HRQL) SCORES AND WORK-RELATED OUTCOMES IN ONCOLOGY

Author(s)

Rendas-Baum R1, Bayliss M1, Bal V2, DAlessio DL2, Bjorner JB3
1Optum, Lincoln, RI, USA, 2Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA, 3Optum Outcomes, Lincoln, RI, USA

OBJECTIVES:  The impact of health-related quality of life (HRQL) on work-outcomes, such as absenteeism and presenteeism, has been examined; however, this impact has not been clearly quantified specifically in samples of oncology patients. This study quantified the association between differences in SF-12v2® Health Survey (SF-12v2) physical or mental component scores (PCS and MCS) scores and work-related outcomes among patients with cancer not in remission. METHODS:  Data came from adult participants in the Medical Expenditure Panel Survey who completed at least one SF-12v2 questionnaire and reported a diagnosis of cancer not in remission (n=548). Generalized linear mixed models were used with absenteeism (percentage of lost days of paid and unpaid work) and presenteeism (serious cognitive limitations) as the outcome. Predictors included SF-12v2 PCS and MCS with sociodemographic factors as covariates. Analyses examined these effects in the entire sample and specifically among employed patients. RESULTS:  A five-point greater (more favorable) PCS and MCS score was associated with 9% and 20% lower odds, respectively, of having lost work days. Among employed subjects, a 5-point greater PCS and MCS score was associated with 20% and 24% lower odds of missing work days, respectively. A five-point greater PCS and MCS was also associated with 24% and 33% decline, respectively, in the odds of experiencing serious cognitive limitations; among employed subjects, the decline in the odds of experiencing cognitive limitations were 12% and 38%, for a 5-point greater PCS and MCS, respectively. CONCLUSIONS:  Better PCS and MCS scores were associated with lower odds of missing work days and experiencing serious cognitive difficulties, suggesting a close link between improved HRQL scores and declines in absenteeism and presenteeism. These findings can be a potential guide in evaluation of outcomes in oncology. Future research should explore whether these US based results can be generalized to an international oncology population.

Conference/Value in Health Info

2017-05, ISPOR 2017, Boston, MA, USA

Value in Health, Vol. 20, No. 5 (May 2017)

Code

PCN195

Topic

Patient-Centered Research

Topic Subcategory

Patient-reported Outcomes & Quality of Life Outcomes

Disease

Oncology

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×